Wednesday, November 25, 2009, 8:57am SGT - The Singapore stock market opens in 3 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

ULURU Inc. (ULU)

At 5:00AM SGT: 0.1295 USD  Up 0.0068 (5.54%)  
 MORE ON ULU 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 ULURU INC (AMEX:ULU) Delayed quote dataEdit
Last Trade:0.1295 USD
Trade Time:5:00AM SGT
Change:Up 0.0068 (5.54%)
Prev Close:0.1227
Open:0.13
Bid:N/A
Ask:N/A
1y Target Est:N/A
Day's Range:0.1228 - 0.13
52wk Range:0.10 - 0.49
Volume:988,384
Avg Vol (3m):1,568,070
Market Cap:8.56M
P/E (ttm):N/A
EPS (ttm):-0.178
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add ULU to Portfolio   Download Data

 HEADLINES 
•ULURU INC. Financials
EDGAR Online Financials (Sun, Nov 22)
•ULURU INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 17)
•ULURU Inc. Reports Third Quarter 2009 Financial Results
PR Newswire (Tue, Nov 17)
•ULURU INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Nov 17)
•ULURU Inc. to Raise $1.5 Million in Registered Direct Offering
PR Newswire (Thu, Nov 12)
•ULURU INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Thu, Nov 12)
•ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
PR Newswire (Tue, Nov 3)
•ULURU Inc. Announces Poster Presentation of Dr. Gregory Bohn
PR Newswire (Sat, Oct 24)
•ULURU Inc. Announces Poster Presentation on the Use of Altrazeal(TM) in Home Care
PR Newswire (Thu, Oct 22)
•ULURU Inc. Announces Extensive Clinical Evidence Presented at the 24th Annual 'Clinical Symposium on Advances in Skin and Wound Care'
PR Newswire (Wed, Oct 21)
More Headlines for ULU...
 ANALYST 
EPS Est (next year) (Jan-70) :N/A
EPS Est (in 2 years) (Jan-70) :N/A
Avg Rec (current)*:2.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Uluru Inc., a pharmaceutical company, engages in the research, development, and commercialization of wound management and oral care products worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices